Evidence map›Paper›PMID 27810924›Full record

ArticleThe Journal of experimental medicine2016

Single-cell imaging of normal and malignant cell engraftment into optically clear prkdc-null SCID zebrafish.

John C Moore, Qin Tang, Nora Torres Yordán, Finola E Moore, Elaine G Garcia, Riadh Lobbardi, Ashwin Ramakrishnan, Dieuwke L Marvin, Anthony Anselmo, Ruslan I Sadreyev and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 2 pooled it
3.4field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 2 syntheses or guidelines pooled it, 73 citations in OpenAlex.

  1. Advancements in Zebrafish Models for Breast Cancer Research: Unveiling Biomarkers, Targeted Therapies, and Personalized Medicine.Medical science monitor : international medical journal of experimental and clinical research · 2023
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. One Host-Multiple Applications: Zebrafish (International journal of molecular sciences · 2022
    Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Zebrafish Xenograft Model to Study Human Cancer.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

John C MooreMolecular Pathology, Massachusetts General Hospital, Charlestown, MA 02129.ORCID 0000-0002-3419-0151
Qin TangMolecular Pathology, Massachusetts General Hospital, Charlestown, MA 02129.ORCID 0000-0002-9487-570X
Nora Torres YordánHarvard Stem Cell Institute, Cambridge, MA 02139.ORCID 0000-0001-6105-3446
Finola E MooreMolecular Pathology, Massachusetts General Hospital, Charlestown, MA 02129.
Elaine G GarciaMolecular Pathology, Massachusetts General Hospital, Charlestown, MA 02129.ORCID 0000-0002-4443-6477
Riadh LobbardiMolecular Pathology, Massachusetts General Hospital, Charlestown, MA 02129.ORCID 0000-0002-8310-7991
Ashwin RamakrishnanMolecular Pathology, Massachusetts General Hospital, Charlestown, MA 02129.ORCID 0000-0003-1569-6664
Dieuwke L MarvinCancer Center, Massachusetts General Hospital, Charlestown, MA 02129.ORCID 0000-0002-3226-7573
Anthony AnselmoDepartment of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114.ORCID 0000-0002-4761-1541
Ruslan I SadreyevDepartment of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114.
David M LangenauMolecular Pathology, Massachusetts General Hospital, Charlestown, MA 02129 dlangenau@mgh.harvard.edu.ORCID 0000-0001-6664-8318
Massachusetts General Hospital · USHarvard University · USHarvard University Press · US

Funding

VectorP30CA006516 · NCI · DANA-FARBER CANCER INSTITUTE · PI Deborah J Goff · 1985 to 2026
$330.6M
Tissue and Pathology ResourcesU54CA168512 · NCI · SARC · PI POLLOCK, RAPHAEL E. · 2012 to 2016
$11.0M
Immune Compromises Zebrafish for Cell TransplantationR24OD016761 · OD · MASSACHUSETTS GENERAL HOSPITAL · PI LANGENAU, DAVID MICHAEL · 2013 to 2021
$5.2M
Genetics of RhabdomyosarcomaR01CA154923 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI LANGENAU, DAVID MICHAEL · 2011 to 2021
$3.8M
Influx Flow CytometerS10OD016372 · OD · MASSACHUSETTS GENERAL HOSPITAL · PI PREFFER, FREDERIC IRA · 2013 to 2013
$600k
ImageStream X Analyzer 2011S10OD012027 · OD · MASSACHUSETTS GENERAL HOSPITAL · PI PREFFER, FREDERIC IRA · 2012 to 2012
$595k
Translational Immunology Core's FACSAria Cell SorterS10RR023440 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI PREFFER, FREDERIC IRA · 2008 to 2008
$500k
DEPARTMENT OF PATHOLOGY LSR2 CYTOMETER: TRANSPLANTATIONS10RR020936 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI PREFFER, FREDERIC IRA · 2005 to 2005
$389k
NCI NIH HHS P30 CA006516NCI NIH HHS R01 CA154923NCI NIH HHS U54 CA168512NCRR NIH HHS S10 RR020936NCRR NIH HHS S10 RR023440NIH HHS R24 OD016761NIH HHS S10 OD012027NIH HHS S10 OD016372
6 · The paper itself

Abstract

Cell transplantation into immunodeficient mice has revolutionized our understanding of regeneration, stem cell self-renewal, and cancer; yet models for direct imaging of engrafted cells has been limited. Here, we characterize zebrafish with mutations in recombination activating gene 2 (rag2), DNA-dependent protein kinase (prkdc), and janus kinase 3 (jak3). Histology, RNA sequencing, and single-cell transcriptional profiling of blood showed that rag2 hypomorphic mutant zebrafish lack T cells, whereas prkdc deficiency results in loss of mature T and B cells and jak3 in T and putative Natural Killer cells. Although all mutant lines engraft fluorescently labeled normal and malignant cells, only the prkdc mutant fish reproduced as homozygotes and also survived injury after cell transplantation. Engraftment into optically clear casper, prkdc-mutant zebrafish facilitated dynamic live cell imaging of muscle regeneration, repopulation of muscle stem cells within their endogenous niche, and muscle fiber fusion at single-cell resolution. Serial imaging approaches also uncovered stochasticity in fluorescently labeled leukemia regrowth after competitive cell transplantation into prkdc mutant fish, providing refined models to assess clonal dominance and progression in the zebrafish. Our experiments provide an optimized and facile transplantation model, the casper, prkdc mutant zebrafish, for efficient engraftment and direct visualization of fluorescently labeled normal and malignant cells at single-cell resolution.

Indexed as

Neoplasm TransplantationOptical PhenomenaAnemiaAnimalsBase SequenceClone CellsDisease Models, AnimalDNA-Activated Protein KinaseGamma RaysHomozygoteHumansImaging, Three-DimensionalImmunocompromised HostLuminescent ProteinsMuscle CellsMutationDNA-Activated Protein KinaseLuminescent ProteinsPrkdc protein, zebrafishProto-Oncogene Proteins c-mycRed Fluorescent ProteinZebrafish Proteins

Identifiers

PMID27810924
PMCPMC5110017
OpenAlexW2538860847

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.